IPA Announces Resignation of Director
“On behalf of the Company and the Board of Directors, I would like to thank Paul for serving on our Board of Directors. His insightful and experienced contributions were highly valued, and we wish Paul all the best in his future endeavours,” commented
As a result of Mr. Andreola’s resignation,
About
ImmunoPrecise is an innovation-driven technology platform company that supports its business partners in their quest to discover and develop novel antibodies against a broad range of classes of disease targets. The Company endeavors to transform the conventional multi-vendor antibody discovery model by providing a comprehensive suite of services tailored to optimize antibody genetic diversity and epitope coverage, to discover antibodies against rare and/or challenging epitopes.
For further information, visit www.immunoprecise.com.
Neither the
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006650/en/
IPA investor contact:
E-mail : jmullaly@lifesciadvisors.com
Source: